These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27194138)

  • 1. [IF-RT alone remains gold standard for stage IA nodular lymphocyte-predominant Hodgkin lymphoma].
    Pilz K; Jentsch C; Krause M
    Strahlenther Onkol; 2016 Jun; 192(6):428-30. PubMed ID: 27194138
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-Term Course of Patients With Stage IA Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the German Hodgkin Study Group.
    Eichenauer DA; Plütschow A; Fuchs M; von Tresckow B; Böll B; Behringer K; Diehl V; Eich HT; Borchmann P; Engert A
    J Clin Oncol; 2015 Sep; 33(26):2857-62. PubMed ID: 26240235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nodular lymphocyte predominant Hodgkin lymphoma behaves as a distinct clinical entity with good outcome: evidence from 14-year follow-up in the West of Scotland Cancer Network.
    Farrell K; McKay P; Leach M
    Leuk Lymphoma; 2011 Oct; 52(10):1920-8. PubMed ID: 21663507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease.
    Bodis S; Kraus MD; Pinkus G; Silver B; Kadin ME; Canellos GP; Shulman LN; Tarbell NJ; Mauch PM
    J Clin Oncol; 1997 Sep; 15(9):3060-6. PubMed ID: 9294468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult nodular lymphocyte-predominant Hodgkin lymphoma: treatment modality utilization and survival.
    Alonso C; Dutta SW; Mitra N; Landsburg DJ; Zaorsky NG; Grover S; Peterson J; Trifiletti DM
    Cancer Med; 2018 Apr; 7(4):1118-1126. PubMed ID: 29479868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines for the investigation and management of nodular lymphocyte predominant Hodgkin lymphoma.
    McKay P; Fielding P; Gallop-Evans E; Hall GW; Lambert J; Leach M; Marafioti T; McNamara C;
    Br J Haematol; 2016 Jan; 172(1):32-43. PubMed ID: 26538004
    [No Abstract]   [Full Text] [Related]  

  • 7. The stage-specific roles of radiotherapy and chemotherapy in nodular lymphocyte predominant Hodgkin lymphoma patients: a propensity score-matched analysis of the SEER database.
    Wang S; Jia M; Han J; Zhang R; Huang K; Qiao Y; Chen P; Fu Z
    Cancer Med; 2021 Jan; 10(2):540-551. PubMed ID: 33249743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nodular lymphocyte-predominant Hodgkin lymphoma in children: clinical course, biology, and management].
    Gorde-Grosjean S; Guimard G; Lambilliotte A; Coulomb-Lhermine A; Montravers F; Landman-Parker J
    Bull Cancer; 2014 Sep; 101(9):881-90. PubMed ID: 25296072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frontline management of nodular lymphocyte predominant Hodgkin lymphoma - a retrospective UK multicentre study.
    Wilson MR; Bagguley T; Smith A; Roman E; Patmore R; Hanlon K; Leach M; Bishton M; Burton C; McKay P
    Br J Haematol; 2019 Sep; 186(6):e214-e217. PubMed ID: 31344253
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hodgkin lymphoma (Hodgkin disease)].
    Naumann UK; Käser L; Vetter W
    Praxis (Bern 1994); 2006 Nov; 95(44):1697-703; quiz 1704, 1706. PubMed ID: 17111877
    [No Abstract]   [Full Text] [Related]  

  • 11. Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective study.
    Lazarovici J; Dartigues P; Brice P; Obéric L; Gaillard I; Hunault-Berger M; Broussais-Guillaumot F; Gyan E; Bologna S; Nicolas-Virelizier E; Touati M; Casasnovas O; Delarue R; Orsini-Piocelle F; Stamatoullas A; Gabarre J; Fornecker LM; Gastinne T; Peyrade F; Roland V; Bachy E; André M; Mounier N; Fermé C
    Haematologica; 2015 Dec; 100(12):1579-86. PubMed ID: 26430172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease.
    Diehl V; Sextro M; Franklin J; Hansmann ML; Harris N; Jaffe E; Poppema S; Harris M; Franssila K; van Krieken J; Marafioti T; Anagnostopoulos I; Stein H
    J Clin Oncol; 1999 Mar; 17(3):776-83. PubMed ID: 10071266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resection alone in 58 children with limited stage, lymphocyte-predominant Hodgkin lymphoma-experience from the European network group on pediatric Hodgkin lymphoma.
    Mauz-Körholz C; Gorde-Grosjean S; Hasenclever D; Shankar A; Dörffel W; Wallace WH; Schellong G; Robert A; Körholz D; Oberlin O; Hall GW; Landman-Parker J
    Cancer; 2007 Jul; 110(1):179-85. PubMed ID: 17526010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coping With Knife: Postoperative Management of Nodular Lymphocyte Predominant Hodgkin Lymphoma.
    Rana S; Holland J
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):547-548. PubMed ID: 29413265
    [No Abstract]   [Full Text] [Related]  

  • 15. Early-stage, lymphocyte-predominant Hodgkin's lymphoma: patient outcomes from a large, single-institution series with long follow-up.
    Chen RC; Chin MS; Ng AK; Feng Y; Neuberg D; Silver B; Pinkus GS; Stevenson MA; Mauch PM
    J Clin Oncol; 2010 Jan; 28(1):136-41. PubMed ID: 19933914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An unusual clinical and pathological presentation of a nodular lymphocyte predominant Hodgkin lymphoma ("Poppema Lennert" lymphoma).
    Ben Rejeb S; Dhaoui A; Ben Ghachem D; Jomni T; Abouda M; Abouda M; Turki S; Bellil K
    Tunis Med; 2016 Feb; 94(2):159-61. PubMed ID: 27532537
    [No Abstract]   [Full Text] [Related]  

  • 17. Modern management of lymphocyte-predominant Hodgkin lymphoma.
    Xing KH; Savage KJ
    Br J Haematol; 2013 May; 161(3):316-29. PubMed ID: 23398605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Race-specific features and outcomes of nodular lymphocyte-predominant Hodgkin lymphoma: Analysis of the National Cancer Data Base.
    Olszewski AJ; Shrestha R; Cook NM
    Cancer; 2015 Oct; 121(19):3472-80. PubMed ID: 26149294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variant histology nodular lymphocyte predominant Hodgkin lymphoma - a route to transformation?
    Szychot E; Shankar A; Haider A; Ramsay A
    Br J Haematol; 2018 May; 181(3):403-406. PubMed ID: 28369705
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of initial characteristics and long-term outcome of patients with lymphocyte-predominant Hodgkin lymphoma and classical Hodgkin lymphoma at clinical stages IA and IIA prospectively treated by brief anthracycline-based chemotherapies plus extended high-dose irradiation.
    Feugier P; Labouyrie E; Djeridane M; Jenabian A; Dubruille V; Berthou C; Ghandour C; Desablens B; Chaït Y; Casassus P; Delwail V; Ifrah N; Le Mevel A; Lamy T; Brière J; Colonna P; Andrieu JM
    Blood; 2004 Nov; 104(9):2675-81. PubMed ID: 15231567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.